Andrea Manni at Penn State University College of Medicine
This study at Penn State Milton S. Hershey Medical Center, in Hershey, is investigating whether combining raloxifene with a dietary supplement called omega-3 fatty acid has an effect on breast density or urine and blood chemicals associated with breast cancer development. The researchers wanted to enroll 372 volunteers. The Call to Action for this study was sent to Army of Women members on March 17, 2010. When the researchers closed enrollment on April 2, 2012, the Army of Women had provided them with 342 women who were interested in enrolling in the study.
- Influence of Obesity on Breast Density Reduction by Omega-3 Fatty Acids: Evidence from a Randomized Clinical Trial
- Administration of omega-3 fatty acids and Raloxifene to women at high risk of breast cancer: interim feasibility and biomarkers analysis from a clinical trial